UBS Group’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,608
| Closed | -$29.7K | – | 9005 |
|
|
2023
Q4 | $29.7K | Buy |
2,608
+2,554
| +4,730% | +$29K | ﹤0.01% | 5649 |
|
|
2023
Q3 | $218 | Sell |
54
-260
| -83% | -$1.05K | ﹤0.01% | 7536 |
|
|
2023
Q2 | $2.23K | Buy |
314
+60
| +24% | +$426 | ﹤0.01% | 6703 |
|
|
2023
Q1 | $1.89K | Hold |
254
| – | – | ﹤0.01% | 7525 |
|
|
2022
Q4 | $1.86K | Buy |
254
+3
| +1% | +$22 | ﹤0.01% | 8581 |
|
|
2022
Q3 | $2K | Buy |
251
+187
| +292% | +$1.49K | ﹤0.01% | 8737 |
|
|
2022
Q2 | $1K | Sell |
64
-246
| -79% | -$3.84K | ﹤0.01% | 9052 |
|
|
2022
Q1 | $15K | Sell |
310
-476
| -61% | -$23K | ﹤0.01% | 6827 |
|
|
2021
Q4 | $59K | Buy |
786
+740
| +1,609% | +$55.5K | ﹤0.01% | 5667 |
|
|
2021
Q3 | $4K | Sell |
46
-641
| -93% | -$55.7K | ﹤0.01% | 7573 |
|
|
2021
Q2 | $96K | Buy |
687
+614
| +841% | +$85.8K | ﹤0.01% | 4875 |
|
|
2021
Q1 | $15K | Buy |
73
+71
| +3,550% | +$14.6K | ﹤0.01% | 6619 |
|
|
2020
Q4 | $0 | Sell |
2
-312
| -99% | – | ﹤0.01% | 7763 |
|
|
2020
Q3 | $53K | Sell |
314
-366
| -54% | -$61.8K | ﹤0.01% | 4761 |
|
|
2020
Q2 | $113K | Sell |
680
-101
| -13% | -$16.8K | ﹤0.01% | 4395 |
|
|
2020
Q1 | $91K | Sell |
781
-565
| -42% | -$65.8K | ﹤0.01% | 4510 |
|
|
2019
Q4 | $199K | Buy |
1,346
+777
| +137% | +$115K | ﹤0.01% | 4607 |
|
|
2019
Q3 | $78K | Buy |
569
+463
| +437% | +$63.5K | ﹤0.01% | 4988 |
|
|
2019
Q2 | $14K | Buy |
+106
| New | +$14K | ﹤0.01% | 5987 |
|